Salarius Pharmaceuticals Inc. share price logo

Salarius Pharmaceuticals Inc. Share Price

NASDAQ: SLRX

$0.83

+0.18

(+27.82%)

as on

Bell Icon

The stock has been delisted from the stock exchange on 7 Jan 2026

Salarius Pharmaceuticals Inc. Stock Performance

as on January 8, 2026 at 2:29 am IST

  • Day's Low

    Day's High

    $0.69
    $0.89
    downward going graph

    16.87%

    Downside

    7.23%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.51
    $108
    downward going graph

    37.98%

    Downside

    12912.05%

    Upside

    downward going graph

Salarius Pharmaceuticals Inc. share price movements today

Previous Close
$0.65
Open
$0.73
Volume
5.8M
Day's Low - High
$0.69 - $0.89
52 Week Low - High
$0.51 - $108

Salarius Pharmaceuticals Inc. Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Salarius Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Salarius Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Salarius Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Salarius Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$-NANA0.00%
BUY$36.3B406.3%-16.34-264.83%
BUY$55.8B172.33%1408.331.36%
BUY$124.1B98.18%34.0231.35%
BUY$86.1B60.61%19.4632.13%

Analyst Recommendation on Salarius Pharmaceuticals Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Salarius Pharmaceuticals Inc.. Average target price of $26

Salarius Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Salarius Pharmaceuticals Inc..

What analysts predicted

96.81%UPSIDE

Target Price

$26

Current Price

$0.83

Analyzed by

6 Analysts

Target

$26.00

Salarius Pharmaceuticals Inc. target price $26, a slight upside of 96.81% compared to current price of $0.83. According to 6 analysts rating.

Salarius Pharmaceuticals Inc. Stock’s Investor Sentiment and Interest

Search interest for Salarius Pharmaceuticals Inc. Stock has decreased by -65% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-65% versus previous 30 day period

Salarius Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
-
-
-
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-2
0
-1
-1
0
-1
-1
0
0
Net Profit Margin
0.00%
0.00%
-4928.44%
0.00%
0.00%
0.00%
-33075.76%
0.00%
0.00%
0.00%

Salarius Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
1
0
3
5
1
-
-
-
Gross Profit
0
0
0
3
5
1
0
0
0
Operating Income
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-39
-34
-21
-6
-7
-12
-31
-12
-5
Net Profit Margin
-3906.33%
-2700.71%
-2615.99%
-200.18%
-140.49%
-693.84%
0.00%
0.00%
0.00%

Global Institutional Holdings in Salarius Pharmaceuticals Inc.

Funds
Holdings
BlackRock Inc
0%
Mascagni Wealth Management, Inc.
0%
TWO SIGMA SECURITIES, LLC
0%
Cubist Systematic Strategies, LLC
0.22%
Morgan Stanley - Brokerage Accounts
0%

Insights on Salarius Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SLRX stock has moved up by 28.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 889.3% return, outperforming this stock by 989.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 167.8% return, outperforming this stock by 264.4%

About Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing its pipeline of peptide conjugate therapeutics engineered through its IMP3ACT platform that reduces the complexity of drug development and manufacturing. It is focused on developing effective treatments for patients with cancer with high, unmet medical needs. The company’s lead candidate, seclidemstat (SP-2577), is being studied as treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options. Its pipeline consists of SP-3164 a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. SP-3164 is a next-generation cereblon-binding MG. SP-2577 is a small-molecule LSD1 inhibitor with a novel scaffold.
OrganisationSalarius Pharmaceuticals Inc.
E-voting on sharesClick here to vote

FAQs

What is Salarius Pharmaceuticals Inc. share price today?

Salarius Pharmaceuticals Inc. share price today is $0.83 as on at the close of the market. Salarius Pharmaceuticals Inc. share today touched a day high of $0.89 and a low of $0.69.

What is the 52 week high and 52 week low for Salarius Pharmaceuticals Inc. share?

Salarius Pharmaceuticals Inc. share touched a 52 week high of $108 on and a 52 week low of $0.51 on . Salarius Pharmaceuticals Inc. stock price today i.e. is closed at $0.83,which is 99.23% down from its 52 week high and 61.23% up from its 52 week low.

How to invest in Salarius Pharmaceuticals Inc. Stock (SLRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Salarius Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Salarius Pharmaceuticals Inc. Shares that will get you 1.8072 shares as per Salarius Pharmaceuticals Inc. share price of $0.83 per share as on January 8, 2026 at 2:29 am IST.

What is the minimum amount required to buy Salarius Pharmaceuticals Inc. Stock (SLRX) from India?

Indian investors can start investing in Salarius Pharmaceuticals Inc. (SLRX) shares with as little as ₹89.918 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.18 in Salarius Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Salarius Pharmaceuticals Inc. share’s latest price of $0.83 as on January 8, 2026 at 2:29 am IST, you will get 12.0482 shares of Salarius Pharmaceuticals Inc.. Learn more about fractional shares .